ReviewChemical research in toxicology2026
Mixture Toxicity in Human Health: Integrating One Health, Exposomics, and Modern Risk Assessment Strategies.
Review in Chemical research in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Exposome influences: a multi-omics perspective on the combined toxic effects of pharmaceuticals and personal care products in Alzheimer's disease.Frontiers in toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human and environmental health are critically threatened by combined exposures to multiple chemical toxicants, including industrial chemicals, heavy metals, pesticides, endocrine-disrupting chemicals (EDCs), and per- and polyfluoroalkyl substances (PFAS). These substances interact biologically, producing additive, synergistic, or antagonistic effects that conventional single-substance risk assessments fail to predict. This leads to a systematic underestimation of health risks, particularly for vulnerable populations. Despite robust evidence on mixture toxicity, major regulatory frameworks such as the US Toxic Substances Control Act (TSCA) and the EU's REACH program continue to assess chemicals in isolation. This review synthesizes current science on toxicant interactions and critiques global regulatory shortcomings, underscoring the real-world consequences through case studies on PFAS, heavy metals, and pesticide mixtures. It advocates for a paradigm shift, proposing reforms that integrate emerging tools like exposomics and computational toxicology with holistic frameworks such as One Health. We highlight pioneering regulatory efforts, including Canada's mandate for cumulative risk assessments under CEPA and the EU's development of mixture assessment factors (MAFs), as essential models for progress. Our recommendations include mandating science-based mixture assessments, harmonizing global standards, and implementing equity-driven policies to align regulations with the reality of multichemical exposures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.